Antares Pharma Inc. - Improving Pharmaceuticals Through Advanced Drug Delivery Systems

Home | Site Index | Contact | Disclaimer

UPDATE

ANTUROL™ at the 28th Annual Scientific Meeting

of the American Urogynecologic Society
[ learn more ]

Approved for Marketing

Elestrin™
low dose estradiol ATD™ gel launched June 2007

Medi-Jector VISION®

needle-free device for use with insulin

ZomaJet® 2 Vision
marketed by Ferring for hGH in Europe

Twin-Jector® EZ II
marketed by JCR Pharmaceuticals Co. Ltd. for hGH in Japan

SciTojet2™
marketed by SciGen Ltd. for hGH in Asia

Ibuprofen gel
in 11 countries

Improving Pharmaceuticals Through
Advanced Drug Delivery Systems

Antares Pharma is committed to developing and commercializing novel therapeutic products utilizing our unique, advanced drug delivery systems. Our products are patient focused: they typically improve safety and efficacy, reduce side effects and enable us to deliver a lower dose. Our advanced drug delivery systems are also well positioned for “life cycle extension” options. We believe that we offer a distinct value to patients, physicians and our shareholders.